BioMerieux SA
BIM: XPAR (FRA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| ZR | LOCK|n!@! | LOCK|??SpHtF |
BioMérieux: Rising Competition Drives a More Cautious Outlook
Business Strategy and Outlook
BioMérieux is a specialist in the fragmented in vitro diagnostics market, with expertise in microbiology testing and syndromic molecular testing, while also active in the immunoassays market.
